Transgenomic has appointed Paul Kinnon to president and CEO, replacing Craig Tuttle. Kinnon will also serve as a director on the company's board. He previously provided commercial and strategic consultancy services to Transgenomics and other life science companies. He was also CEO of ZyGem and previously held positions at Invitrogen, Guava Technologies, and Cellomics.
People in the News: Paul Kinnon
Oct 02, 2013